Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
Relay Therapeutics (Nasdaq: RLAY) will report third quarter 2025 financial results and corporate highlights after U.S. financial markets close on Thursday, November 6, 2025.
The company is a clinical-stage precision medicine firm combining computational and experimental technologies in drug discovery and is based in Cambridge, Mass.
Relay Therapeutics (Nasdaq: RLAY) riporterà i risultati finanziari del terzo trimestre 2025 e i principali eventi aziendali dopo la chiusura dei mercati finanziari statunitensi giovedì 6 novembre 2025.
L'azienda è una società di medicina di precisione in fase clinica che combina tecnologie computazionali ed esperimentali nella scoperta di farmaci ed ha sede a Cambridge, Mass.
Relay Therapeutics (Nasdaq: RLAY) informará los resultados financieros del tercer trimestre de 2025 y los aspectos destacados de la empresa después del cierre de los mercados financieros de Estados Unidos el jueves 6 de noviembre de 2025.
La empresa es una firma de medicina de precisión en etapa clínica que combina tecnologías computacionales y experimentales en el descubrimiento de fármacos y tiene su sede en Cambridge, Mass.
Relay Therapeutics (Nasdaq: RLAY)는 미국 주식 시장 마감 후 2025년 3분기 재무 실적 및 기업 하이라이트를 발표할 예정이며 2025년 11월 6일 목요일에 발표합니다.
이 회사는 컴퓨테이셔널 및 실험 기술을 결합한 임상 단계의 정밀의약품 기업이며 케임브리지, 매사추세츠에 본사를 두고 있습니다.
Relay Therapeutics (Nasdaq: RLAY) annoncera les résultats financiers du troisième trimestre 2025 et les temps forts de l'entreprise après la clôture des marchés financiers américains le jeudi 6 novembre 2025.
L'entreprise est une société de médecine de précision en phase clinique qui combine des technologies computationnelles et expérimentales dans la découverte de médicaments et est basée à Cambridge, Mass.
Relay Therapeutics (Nasdaq: RLAY) wird die finanziellen Ergebnisse des dritten Quartals 2025 und Unternehmenshöhepunkte nach dem Handelsschluss der US-Märkte am Donnerstag, dem 6. November 2025 berichten.
Das Unternehmen ist ein klinischer Stand der Präzisionsmedizin-Firma, die computergestützte und experimentelle Technologien in der Wirkstoffforschung kombiniert und hat ihren Sitz in Cambridge, Mass.
Relay Therapeutics (Nasdaq: RLAY) ستعلن النتائج المالية للربع الثالث من 2025 وأبرز أحداث الشركة بعد إغلاق أسواق المال الأمريكية يوم الخميس 6 نوفمبر 2025.
الشركة هي شركة أدوية دقيقة في المرحلة السريرية تجمع بين التقنيات الحاسوبية والتجريبية في اكتشاف الأدوية ومقرها في كامبريدج، ماساتشوستس.
- None.
- None.
CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025 financial results and corporate highlights after the U.S. financial markets close on Thursday, November 6, 2025.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease. Relay's Dynamo® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The company’s lead clinical asset, RLY-2608, is the first pan-mutant selective PI3Kα inhibitor to enter clinical development and is currently in a Phase 3 clinical trial (ReDiscover-2) in HR+/HER2- metastatic breast cancer. RLY-2608 is also being investigated in a group of genetic disease indications called PI3Kα-driven vascular malformations. Relay's pipeline also includes late-stage research programs for NRAS-driven solid tumors and Fabry disease. For more information, please visit www.relaytx.com or follow us on LinkedIn.
Contact:
Pete Rahmer
prahmer@relaytx.com
Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com
FAQ
When will Relay Therapeutics (RLAY) report third quarter 2025 results?
What will Relay Therapeutics announce on November 6, 2025 for RLAY?
What is the Nasdaq ticker for Relay Therapeutics and where is it based?
Does the October 30, 2025 notice include Q3 2025 financial figures for RLAY?
What should investors expect in the November 6, 2025 Relay Therapeutics announcement (RLAY)?
